- two doses needed, 3 weeks apart, immunity after one month from first dose. Slow rollout.
- -80C storage and transport needed. Challenging, but doable in developed countries, but still may slow down mass rollout. Not feasible in many developing countries.
I still wonder about long-term immunity. Anyone can share any insight?
+ ~90% of individuals achieve immunity.
+ no significant side-effects.
Not so good:
- two doses needed, 3 weeks apart, immunity after one month from first dose. Slow rollout.
- -80C storage and transport needed. Challenging, but doable in developed countries, but still may slow down mass rollout. Not feasible in many developing countries.
I still wonder about long-term immunity. Anyone can share any insight?